UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Bio-physical removal of heavy metal from aqueous solution

Desalination and water treatment, 2016-12, Vol.57 (59), p.28932-28938

2016

Volltextzugriff (PDF)

Derived hybrid biosorbent for zinc(II) removal from aqueous solution by continuous-flow activated sludge system

Journal of water process engineering, 2020-04, Vol.34, p.101152, Article 101152

2020

Volltextzugriff (PDF)

Kinetics of heavy metal removal in a suspended and immobilized bioreactors

IOP conference series. Materials Science and Engineering, 2017-06, Vol.206 (1), p.12098

2017

Volltextzugriff (PDF)

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

European heart journal, 2020-11, Vol.41 (41), p.3998-4007

2020

Volltextzugriff (PDF)

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

Journal of the American College of Cardiology, 2008-02, Vol.51 (6), p.634-642

2008

Volltextzugriff (PDF)

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

European heart journal, 2018-07, Vol.39 (27), p.2589-2596

2018

Volltextzugriff (PDF)

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women

Journal of the American College of Cardiology, 2009-12, Vol.55 (1), p.35-41

2009

Volltextzugriff (PDF)

C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study

Arteriosclerosis, thrombosis, and vascular biology, 2013-12, Vol.33 (12), p.2888

2013

Volltextzugriff (PDF)

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study

Arteriosclerosis, thrombosis, and vascular biology, 2017-06, Vol.37 (6), p.1206

2017

Volltextzugriff (PDF)

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals : The EPIC-Norfolk prospective population study

Journal of the American College of Cardiology, 2007-07, Vol.50 (2), p.159-165

2007

Volltextzugriff (PDF)

Beyond Low-Density Lipoprotein Cholesterol

Journal of the American College of Cardiology, 2009-12, Vol.55 (1), p.35-41

2009

Volltextzugriff (PDF)

apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study

Journal of the American Heart Association, 2019-08, Vol.8 (16), p.e013020-e013020

2019

Volltextzugriff (PDF)

HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

Atherosclerosis, 2009-09, Vol.206 (1), p.276-281

2009

Volltextzugriff (PDF)

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women : The EPIC-norfolk prospective population study

Journal of the American College of Cardiology, 2007-02, Vol.49 (5), p.547-553

2007

Volltextzugriff (PDF)

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

Annals of internal medicine, 2007-05, Vol.146 (9), p.640

2007

Volltextzugriff (PDF)

Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis

JAMA network open, 2020-02, Vol.3 (2), p.e200129-e200129

2020

Volltextzugriff (PDF)

High-density lipoprotein particle size and concentration and coronary risk

Annals of internal medicine, 2009-01, Vol.150 (2), p.84

2009

Volltextzugriff (PDF)

Effect of Long-Term Low Lipoproteins on Neurocognitive Function

Journal of the American College of Cardiology, 2018-09, Vol.72 (10), p.1176-1177

2018

Volltextzugriff (PDF)

C‐Reactive Protein Identifies Low‐Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer–Norfolk Prospective Population Study

Journal of the American Heart Association, 2016-06, Vol.5 (6), p.n/a

2016

Volltextzugriff (PDF)

Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

International journal of cardiology, 2010-09, Vol.143 (3), p.399-404

2010

Volltextzugriff (PDF)

Apolipoprotein A-II is inversely associated with risk of future coronary artery disease

Circulation (New York, N.Y.), 2007-10, Vol.116 (18), p.2029-2035

2007

Volltextzugriff (PDF)

Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study

PloS one, 2009-08, Vol.4 (8), p.e6809-e6809

2009

Volltextzugriff (PDF)

Lipid assessment, metabolic syndrome and coronary heart disease risk

European journal of clinical investigation, 2010-12, Vol.40 (12), p.1081-1093

2010

Volltextzugriff (PDF)

A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk

Journal of clinical lipidology, 2019-05, Vol.13 (3), p.492-501

2019

Volltextzugriff (PDF)

Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study

Journal of clinical lipidology, 2018-11, Vol.12 (6), p.1493-1501.e11

2018

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Tagungsberichte
(1)

Sprache

Englisch
(33)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bio-physical removal of heavy metal from aqueous solution

Derived hybrid biosorbent for zinc(II) removal from aqueous solution by continuous-flow activated sludge system

Kinetics of heavy metal removal in a suspended and immobilized bioreactors

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women

C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals : The EPIC-Norfolk prospective population study

Beyond Low-Density Lipoprotein Cholesterol

apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study

HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women : The EPIC-norfolk prospective population study

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis

High-density lipoprotein particle size and concentration and coronary risk

Effect of Long-Term Low Lipoproteins on Neurocognitive Function

C‐Reactive Protein Identifies Low‐Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer–Norfolk Prospective Population Study

Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

Apolipoprotein A-II is inversely associated with risk of future coronary artery disease

Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study

Lipid assessment, metabolic syndrome and coronary heart disease risk

A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk

Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study

Suchergebnisse filtern